By Julia Karow

This article was originally published May 12.

In an effort to shore up capital as it expands it human whole-genome sequencing service business, Complete Genomics is offering 4.5 million of its shares in a public offering.

The company also disclosed this month that it has signed a $20 million loan agreement that it will use in part to pay one of several previous loans.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.